The Royal Children's Hospital Melbourne

Research

Members of the pharmacy department are very active in presenting at conferences, both statewide and federally.

Recent past conference paper and poster presentations include:

2006

• Mycoplasma pneumoniae infection-induced Stevens-Johnson syndrome. Yeung S (Poster presentation, presented at the SHPA 5th Biennial Clinical Conference, Melbourne. November 2006) 

2005

• Cryptococcal Meningitis – which antifungals? Yeung S, Deidun D (Oral presentation, presented at the 27th SHPA Federal Conference, Brisbane. November 2005)

• Meloxicam-induced acute liver failure. Plover C, Yeung S (Poster presentation, presented at the 27th SHPA Federal Conference, Brisbane. November 2005)

2004

• Lamotrigine induced rash. A case of accidental re-exposure.Yeung S, Plover C, Titchen T (Poster presentation, presented at the SHPA Clinical Conference, Sydney. October 2004)                                  

2003

• Medication safety, it's in the Palm of your hand! Yeung S, Bogovic A (Oral presentation, presented at the 26th SHPA Federal Conference, Canberra. November 2003)

• Basic patient safety improvements - selecting the right drug on the ward. Bogovic A, Titchen T, Lilley B, Callaghan S (E-poster presentation, presented at the 26th SHPA Federal Conference, Canberra. November 2003)

• Treatment of neonatal diabetes - the pharmacist's perspective. Chan M, Yeung S (E-poster presentation, presented at the 26th SHPA Federal Conference, Canberra. November 2003)

• Assessment and redesign of medication ordering in a tertiary paediatric hospitial.Deidun D, Steel M, Titchen T, Bogovic A (E-poster presentation, presented at the 26th SHPA Federal Conference, Canberra. November 2003)

• A long and winding road - implementing a policy for complementary medicine use in children. Hynes K (E-poster presentation, presented at the 26th SHPA Federal Conference, Canberra. November 2003)

• As smooth as a baby's bottom: the process and the cream! Kemp C (E-poster presentation, presented at the 26th SHPA Federal Conference, Canberra. November 2003)

• Helping children grow - the role of a pharmacy technician in growth hormone distribution at the Royal Children's Hospital. Rowe R (E-poster presentation, presented at the 26th SHPA Federal Conference, Canberra. November 2003)

• Improving management of Helicobacter pylori in general practice. Titchen T, Ching  M, Clark R, Sztendur A, May F, Rowett D (E-poster presentation, presented at the 26th SHPA Federal Conference, Canberra. November 2003)

• Toxic Epidermal Necrolysis - a case of anticonvulsant hypersensitivity syndrome. Zambetis S, Ng C (E-poster presentation, presented at the 26th SHPA Federal Conference, Canberra. November 2003)

2002

• It's a "palm" world after all. The many uses of palm pilots in hospital pharmacy.
  Yeung S, Bogovic A
  (As presented at First Combined NZHPA and SHPA Conference. Christchurch, New Zealand. August 2002)

• Complementary and Alternative Medicines (CAM) Policy inquiries to the Royal Children's Hospital Drug Information Centre
  Roth S, Hynes K
  (As presented at SHPA Victorian State Conference. Bendigo, Victoria, Australia. November 2002)

• Development and Implementation of an Electronic Database for Adverse Drug Reactions.
  Ng C, Titchen T, Cranswick N
  (As presented at SHPA Victorian State Conference. Bendigo, Victoria, Australia. November 2002)

• A multidisciplinary approach to reducing medication errors.
  Lilley B, Titchen T
  (As presented at the National Medicines Symposium. Canberra March 2002)

2001

• Empty Out the Folders and Free Up the Shelves: Creating A Pharmacy-Restricted Intranet Site.
  McDowell JM.
• Go natural? - developing a policy for complementary medicine use in children.
  Hynes KI
• Once-daily administration of tobramycin in children with cystic fibrosis.
  Sudhakaran S, Cranswick N, Massie J
• Sildenafil for the treatment of pulmonary hypertension in children;- never too young for Viagra^ﾮ.
  Sudhakaran S, Bogovic A, Carberry J
• The use of antibiotic flush solutions in paediatric central lines.
  Carberry JS, Parkins P
• Treatment and Effects of Antenatal Bartter Syndrome;- otherwise known as Hyperprostaglandin E₂ Syndrome.
  Tran Z, Stubbs F
• Treatment of neonatal hypoglycaemia;- the pharmacist perspective.
  Yeung S, Bogovic A
• Treatment of opioid-induced pruritus.
  Dyas R, Kavanagh L

(2001 abstracts presented at SHPA Federal Conference. Hobart, Australia. Nov 2002)

2000 and earlier

• Getting the most from an adverse drug reaction program.
  Legge D, Cranswick N, Titchen T
• Reporting Adverse Drug Reactions to Local AnGel Anaesthetic.
  Sudhakaran S, Titchen T
• Pharmacy exchange: an international approach.
  Deidun D,Titchen T
• Raising awareness of latex allergy.
  Titchen T, Sampanthar R
• Pharmacists.com - Riding the cyber wave.
  McDowell JM, Beulke SH
• Epoprostenol Use in the Treatment of Primary Pulmonary Hypertension - An Australian Experience.
  Bogovic A, Parkins P, Carberry J, Rose M
• Case Report of Dalteparin Induced Alopecia.
  Deidun DM , Hynes KI , Monagle PT
• A novel venture proves fruitful for a hospital pharmacy department, then a Network.
  Kemp CA, Munari G, Bencraft MA
• Warfarin Indicators in Paediatrics
  Robinson A, Titchen T
• Managing the shortfall of pharmacy trainees in 2000 with a residency program.
  Muir P, Titchen T, Thomson W, Davies G, Davies J, Poole S, Weeks G
• Amethocaine gel for topical anaesthesia: a stability study using HPLC.
  White B , Titchen T, Bakalova M , Finnin B
• Paediatric emergency department attendances and hospital admissions associated with adverse drug reactions.
  Easton K, Lilley B, Brien J
• Cefpirome Induced Hypersensitivity with the First Dose: An Issue for Hospital in the Home.
  Zambetis S
• Poster Presentations:
  • Customer Satisfaction Survey of Callers to the Victorian Poisons Information Centre.
    Beulke SH
  • What are You Worth?
    Tattersall KS, Bogovic A